Fidelity Blue Chip Growth’s exposure to companies with paltry current earnings, relatively high price multiples, and rapid growth expectations has inflicted heavy losses during the global equity market sell-off that began near 2022’s start. For the year to date through May 7, 2022, the mutual fund's no-load share class slid 27.3%, a bottom-quartile result within the large-growth Morningstar Category that was roughly 6 percentage points worse than the Russell 1000 Growth Index’s decline. That underperformance, while disappointing, is mostly in line with what investors should expect from the strategy, given its style, typical exposure to companies with high volatility, and an unfavorable macroeconomic backdrop.
NAV / 1-Day Return
115.99 / 2.99 %
Adj. Expense Ratio
Longest Manager Tenure
Investment StyleLarge Growth
Min. Initial Investment
Morningstar’s Fund Analysis FBGRX
Will FBGRX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.